These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 27508346)
1. Unidirectional and sustained delivery of the proresolving lipid mediator resolvin D1 from a biodegradable thin film device. Lance KD; Chatterjee A; Wu B; Mottola G; Nuhn H; Lee PP; Sansbury BE; Spite M; Desai TA; Conte MS J Biomed Mater Res A; 2017 Jan; 105(1):31-41. PubMed ID: 27508346 [TBL] [Abstract][Full Text] [Related]
2. Perivascular delivery of resolvin D1 inhibits neointimal hyperplasia in a rat model of arterial injury. Wu B; Mottola G; Chatterjee A; Lance KD; Chen M; Siguenza IO; Desai TA; Conte MS J Vasc Surg; 2017 Jan; 65(1):207-217.e3. PubMed ID: 27034112 [TBL] [Abstract][Full Text] [Related]
3. Perivascular delivery of resolvin D1 inhibits neointimal hyperplasia in a rabbit vein graft model. Wu B; Werlin EC; Chen M; Mottola G; Chatterjee A; Lance KD; Bernards DA; Sansbury BE; Spite M; Desai TA; Conte MS J Vasc Surg; 2018 Dec; 68(6S):188S-200S.e4. PubMed ID: 30064835 [TBL] [Abstract][Full Text] [Related]
4. Aspirin-Triggered Resolvin D1-modified materials promote the accumulation of pro-regenerative immune cell subsets and enhance vascular remodeling. Sok MCP; Tria MC; Olingy CE; San Emeterio CL; Botchwey EA Acta Biomater; 2017 Apr; 53():109-122. PubMed ID: 28213094 [TBL] [Abstract][Full Text] [Related]
5. A pro-angiogenic degradable Mg-poly(lactic-co-glycolic acid) implant combined with rhbFGF in a rat limb ischemia model. Bao H; Lv F; Liu T Acta Biomater; 2017 Dec; 64():279-289. PubMed ID: 28951330 [TBL] [Abstract][Full Text] [Related]
6. 17R/S-Benzo-RvD1, a synthetic resolvin D1 analogue, attenuates neointimal hyperplasia in a rat model of acute vascular injury. Kim AS; Werlin EC; Kagaya H; Chen M; Wu B; Mottola G; Jan M; Conte MS PLoS One; 2022; 17(2):e0264217. PubMed ID: 35226675 [TBL] [Abstract][Full Text] [Related]
7. Regulation of the inflammatory response by vascular grafts modified with Aspirin-Triggered Resolvin D1 promotes blood vessel regeneration. Shi J; Zhang X; Jiang L; Zhang L; Dong Y; Midgley AC; Kong D; Wang S Acta Biomater; 2019 Oct; 97():360-373. PubMed ID: 31351251 [TBL] [Abstract][Full Text] [Related]
9. Tissue factor targeting peptide enhances nanoparticle binding and delivery of a synthetic specialized pro-resolving lipid mediator to injured arteries. Levy ES; Kim AS; Werlin E; Chen M; Sansbury BE; Spite M; Desai TA; Conte MS JVS Vasc Sci; 2023; 4():100126. PubMed ID: 38045567 [TBL] [Abstract][Full Text] [Related]
10. Oral Resolvin D1 attenuates early inflammation but not intimal hyperplasia in a rat carotid angioplasty model. Mottola G; Werlin EC; Wu B; Chen M; Chatterjee A; Schaller MS; Conte MS Prostaglandins Other Lipid Mediat; 2020 Feb; 146():106401. PubMed ID: 31841663 [TBL] [Abstract][Full Text] [Related]
12. Resolvin D1 attenuates imiquimod-induced mice psoriasiform dermatitis through MAPKs and NF-κB pathways. Xu J; Duan X; Hu F; Poorun D; Liu X; Wang X; Zhang S; Gan L; He M; Zhu K; Ming Z; Chen H J Dermatol Sci; 2018 Feb; 89(2):127-135. PubMed ID: 29137840 [TBL] [Abstract][Full Text] [Related]
13. Deferoxamine released from poly(lactic-co-glycolic acid) promotes healing of osteoporotic bone defect via enhanced angiogenesis and osteogenesis. Jia P; Chen H; Kang H; Qi J; Zhao P; Jiang M; Guo L; Zhou Q; Qian ND; Zhou HB; Xu YJ; Fan Y; Deng LF J Biomed Mater Res A; 2016 Oct; 104(10):2515-27. PubMed ID: 27227768 [TBL] [Abstract][Full Text] [Related]
14. Biosynthesis of proresolving lipid mediators by vascular cells and tissues. Chatterjee A; Komshian S; Sansbury BE; Wu B; Mottola G; Chen M; Spite M; Conte MS FASEB J; 2017 Aug; 31(8):3393-3402. PubMed ID: 28442547 [TBL] [Abstract][Full Text] [Related]
15. Exovascular application of epigallocatechin-3-O-gallate-releasing electrospun poly(L-lactide glycolic acid) fiber sheets to reduce intimal hyperplasia in injured abdominal aorta. Lee MH; Kwon BJ; Koo MA; Jang EH; Seon GM; Park JC Biomed Mater; 2015 Sep; 10(5):055010. PubMed ID: 26391656 [TBL] [Abstract][Full Text] [Related]
16. [Rapamycin-loaded poly (lactic-co-glycolic) acid nanoparticles for intraarterial local drug delivery: preparation, characterization, and in vitro/in vivo release]. Miao LF; Yang J; Huang CL; Song CX; Zeng YJ; Chen LF; Zhu WL Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Aug; 30(4):491-7. PubMed ID: 18795627 [TBL] [Abstract][Full Text] [Related]
17. Preparation, characterization and in vivo pharmacodynamic evaluation of thymopentin loaded poly(lactide acid)/poly(lactide-co-glycolide acid) implants. Wei G; Jin L; Xu L; Liu Y; Lu W Int J Pharm; 2010 Oct; 398(1-2):123-9. PubMed ID: 20674730 [TBL] [Abstract][Full Text] [Related]
18. Mechanism(s) of increased vascular cell adhesion on nanostructured poly(lactic-co-glycolic acid) films. Miller DC; Haberstroh KM; Webster TJ J Biomed Mater Res A; 2005 Jun; 73(4):476-84. PubMed ID: 15880725 [TBL] [Abstract][Full Text] [Related]
19. Endogenous expression pattern of resolvin D1 in a rat model of self-resolution of lipopolysaccharide-induced acute respiratory distress syndrome and inflammation. Sun W; Wang ZP; Gui P; Xia W; Xia Z; Zhang XC; Deng QZ; Xuan W; Marie C; Wang LL; Wu QP; Wang T; Lin Y Int Immunopharmacol; 2014 Nov; 23(1):247-53. PubMed ID: 25218162 [TBL] [Abstract][Full Text] [Related]
20. Investigation of DNA damage in cells exposed to poly (lactic-co-glycolic acid) microspheres. Zivkovic L; Akar B; Roux BM; Spremo Potparevic B; Bajic V; Brey EM J Biomed Mater Res A; 2017 Jan; 105(1):284-291. PubMed ID: 27480196 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]